The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of BRCA1 promoter methylation in triple-negative breast cancer (TNBC) with resistance to standard anthracyline-based adjuvant chemotherapy.
P. Sharma
No relevant relationships to disclose
B. F. Kimler
No relevant relationships to disclose
Y. A. Park
No relevant relationships to disclose
S. R. Stecklein
No relevant relationships to disclose
Q. J. Khan
No relevant relationships to disclose
B. K. Petroff
No relevant relationships to disclose
O. W. Tawfik
No relevant relationships to disclose
R. A. Jensen
No relevant relationships to disclose